Nat Rev Cancer. 2007 Aug;7(8):628-33. Epub 2007 Jul 5.

The disappearing Barr body in breast and ovarian cancers.

Pageau GJ, Hall LL, Ganesan S, Livingston DM, Lawrence JB.

Source

Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

Abstract

Interest has recently reawakened in whether loss of the heterochromatic X chromosome (Barr body) is prevalent in certain breast and ovarian cancers, and new insights into the mechanisms involved have emerged. Mitotic segregation errors commonly explain the loss of the inactive X chromosome (Xi), but compromise of Xi heterochromatin in some cancers may signal broader deficits of nuclear heterochromatin. The debated link between BRCA1 and Xi might reflect a general relationship between BRCA1 and heterochromatin, which could connect BRCA1 to both epigenetic and genetic instability. We suggest that heterochromatic instability is a common but largely unexplored mechanism, leading to widespread genomic misregulation and the evolution of some cancers.

PMID:: 17611545; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Heterochromatin

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. [J Cell Biochem. 2007]
BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau GJ, Hall LL, Lawrence JB. J Cell Biochem. 2007 Mar 1; 100(4):835-50.
Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. [Cancer Res. 2005]
Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, et al. Cancer Res. 2005 Mar 15; 65(6):2139-46.
Association of BRCA1 with the inactive X chromosome and XIST RNA. [Philos Trans R Soc Lond B Biol...]
Association of BRCA1 with the inactive X chromosome and XIST RNA.
Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM. Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29; 359(1441):123-8.
Review Basal-like subtype and BRCA1 dysfunction in breast cancers. [Int J Clin Oncol. 2008]
Review Basal-like subtype and BRCA1 dysfunction in breast cancers.
Miyoshi Y, Murase K, Oh K. Int J Clin Oncol. 2008 Oct; 13(5):395-400. Epub 2008 Oct 23.
Review X chromosome inactivation: heterogeneity of heterochromatin. [Biochem Cell Biol. 2008]
Review X chromosome inactivation: heterogeneity of heterochromatin.
Sidhu SK, Minks J, Chang SC, Cotton AM, Brown CJ. Biochem Cell Biol. 2008 Oct; 86(5):370-9.

See reviews... See all...

Cited by 8 PubMed Central articles

BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. [Nature. 2011]
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.
Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma IM. Nature. 2011 Sep 7; 477(7363):179-84. Epub 2011 Sep 7.
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy. [PLoS One. 2011]
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.
Hamaï A, Duperrier-Amouriaux K, Pignon P, Raimbaud I, Memeo L, Colarossi C, Canzonieri V, Perin T, Classe JM, Campone M, et al. PLoS One. 2011; 6(6):e21129. Epub 2011 Jun 17.
Review The functional role of long non-coding RNA in human carcinomas. [Mol Cancer. 2011]
Review The functional role of long non-coding RNA in human carcinomas.
Gibb EA, Brown CJ, Lam WL. Mol Cancer. 2011 Apr 13; 10:38. Epub 2011 Apr 13.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The disappearing Barr body in breast and ovarian cancers.
The disappearing Barr body in breast and ovarian cancers.
Nat Rev Cancer. 2007 Aug ;7(8):628-33. Epub 2007 Jul 5 .

PubMed
Technology insight: noninvasive brain stimulation in neurology-perspectives on t...
Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS.
Nat Clin Pract Neurol. 2007 Jul ;3(7):383-93.

PubMed
Glycogen structure and biogenesis.
Glycogen structure and biogenesis.
Int J Biochem. 1991 ;23(12):1335-52.

PubMed
Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in ...
Bin1 homolog hob1 supports a Rad6-Set1 pathway of transcriptional repression in fission yeast.
Cell Cycle. 2007 Jul 1 ;6(13):1655-62. Epub 2007 May 8 .

PubMed
[Dicer efficiently converts large dsRNAs into siRNAs suitable for COX-2 gene].
[Dicer efficiently converts large dsRNAs into siRNAs suitable for COX-2 gene].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007 Jun ;32(3):437-42.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: